Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma.
about
FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy menProtein C anticoagulant and cytoprotective pathwaysActivated protein C action in inflammationAssociation of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene study.Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment.The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies.Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsisEndothelial protein C receptor and pediatric arterial strokePlasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients.Lessons from genome-wide association studies in venous thrombosis.The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling.Current knowledge on the genetics of incident venous thrombosis.Alternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.Circulating endothelial cell protein C receptor: endothelial regulation and cumulative impact of gender and A3 haplotype.The H3 Haplotype of the EPCR Gene Determines High sEPCR Levels in Critically Ill Septic Patients.Anti-inflammatory effects of activated protein C on human dendritic cells.What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologiesGenome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project
P2860
Q24336746-932E1C9C-B1AE-461E-9191-93351CB4BE98Q26999113-8C90E54A-D742-456E-829E-8D69B1B1E3EBQ33846825-FFD0F901-1BA9-4E18-9E09-C4D819D9867AQ34471057-F5FB76BD-2E5B-4D03-A570-657A515C849EQ35805622-80A30773-7410-4341-BCC7-EF7ED5B80A5BQ35849271-A772B630-0A70-49CF-8BB2-1C3AED0E1859Q36487830-B8946123-220A-4132-B751-CFB457A3911EQ37193924-279E67C0-710F-4ACB-8320-6B677CBD28A8Q37313286-E564D93E-0E81-47E3-A7D1-A1493AF4E03FQ37702845-B708CE59-8A6B-407D-B4FD-8418D4C78B4BQ37903948-4D005218-6288-4FCF-9BCC-9786CE3DDC48Q37942050-9D32F166-EB83-42A8-8F7F-0A13151D7B70Q38117729-E99E180C-E999-4D20-BCA1-250DE37B327EQ38762336-2F6C9007-28E6-4E75-98B0-D317640334B0Q42483140-BAF25170-7D06-4B78-A26E-647BF64EE798Q52651076-C8730332-BF55-401E-B49B-AD02AC94873FQ52950237-D87F4412-901A-4508-99F9-012CDBBDEF97Q57611689-EBBD052E-31F0-4BE4-A546-5B2BA24DB641Q57611749-308D15B3-373B-4D79-A429-224BECB4FFD8
P2860
Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Alternative mRNA is favored by ...... oluble form of EPCR in plasma.
@en
Alternative mRNA is favored by ...... oluble form of EPCR in plasma.
@nl
type
label
Alternative mRNA is favored by ...... oluble form of EPCR in plasma.
@en
Alternative mRNA is favored by ...... oluble form of EPCR in plasma.
@nl
prefLabel
Alternative mRNA is favored by ...... oluble form of EPCR in plasma.
@en
Alternative mRNA is favored by ...... oluble form of EPCR in plasma.
@nl
P2093
P2860
P1433
P1476
Alternative mRNA is favored by ...... soluble form of EPCR in plasma
@en
P2093
Anna Lokajczyk
Beatrice Saposnik
Charles T Esmon
Elodie Lesteven
Martine Aiach
P2860
P304
P356
10.1182/BLOOD-2007-08-104968
P407
P577
2007-12-11T00:00:00Z